Literature DB >> 23842286

Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).

Margaret M Esiri1, Catharine Joachim, Carolyn Sloan, Sharon Christie, Grzegorz Agacinski, Leslie R Bridges, Gordon K Wilcock, A David Smith.   

Abstract

The understanding of how cerebrovascular disease (CVD) contributes to dementia is hampered by a lack of agreed and validated pathologic methods to accord weight to the contribution of different aspects of CVD to dementia. A previous study from the Oxford Project to Investigate Memory and Ageing (OPTIMA) validated a scheme for assessing the contribution of subcortical small vessel disease (SVD) toward dementia in the elderly by showing a significant inverse relationship between the severity of SVD and cognition in subjects without any other dementia pathology using this method. In the present paper, the method has been used to assess severity of SVD in 161 cases of neuropathologically confirmed Alzheimer disease. The results showed there was no relationship between the SVD score and cognitive scores acquired in the last 2 years of life. SVD scores were significantly related to age (P<0.0017) and were slightly but significantly higher in females than males (P<0.049). SVD scores were not related to blood pressure at entry to OPTIMA and were significantly lower when compared with the cohort of OPTIMA cases with only CVD (mean 5.06 ± 1.85 vs. 5.9 ± 2.67; P<0.0065). We conclude that when Alzheimer disease pathology is present in elderly subjects, it overwhelms the modest contribution that SVD makes to cognitive impairment.

Entities:  

Mesh:

Year:  2014        PMID: 23842286     DOI: 10.1097/WAD.0b013e31829b72f1

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  17 in total

1.  Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Authors:  Hee Jin Kim; Seongbeom Park; Hanna Cho; Young Kyoung Jang; Jin San Lee; Hyemin Jang; Yeshin Kim; Ko Woon Kim; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Michael W Weiner; William J Jagust; Gil D Rabinovici; Charles DeCarli; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

2.  Dilated perivascular spaces in the Basal Ganglia are a biomarker of small-vessel disease in a very elderly population with dementia.

Authors:  T P Hansen; J Cain; O Thomas; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-19       Impact factor: 3.825

3.  Genetic risk for coronary heart disease alters the influence of Alzheimer's genetic risk on mild cognitive impairment.

Authors:  Jeremy A Elman; Matthew S Panizzon; Mark W Logue; Nathan A Gillespie; Michael C Neale; Chandra A Reynolds; Daniel E Gustavson; Brinda K Rana; Ole A Andreassen; Anders M Dale; Carol E Franz; Michael J Lyons; William S Kremen
Journal:  Neurobiol Aging       Date:  2019-06-08       Impact factor: 4.673

Review 4.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

5.  Cognitive profiles in degenerative dementia without evidence of small vessel pathology and small vessel vascular dementia.

Authors:  Antonella De Carolis; Virginia Cipollini; Nicole Donato; Micaela Sepe-Monti; Francesco Orzi; Franco Giubilei
Journal:  Neurol Sci       Date:  2016-09-21       Impact factor: 3.307

6.  White matter hypoperfusion and damage in dementia: post-mortem assessment.

Authors:  Seth Love; J Scott Miners
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

Review 7.  The overlap between vascular disease and Alzheimer's disease--lessons from pathology.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  BMC Med       Date:  2014-11-11       Impact factor: 8.775

8.  White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yuxin Zhu; Mei-Cheng Wang; Abhay Moghekar; Rebecca F Gottesman; Baljeet Singh; Oliver Martinez; Evan Fletcher; Charles DeCarli; Marilyn Albert
Journal:  Neurology       Date:  2019-12-30       Impact factor: 9.910

9.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

10.  A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain.

Authors:  Ali Ghoochani; Eduard Yakubov; Tina Sehm; Zheng Fan; Stefan Hock; Michael Buchfelder; Ilker Y Eyüpoglu; Nicolai E Savaskan
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.